EndoRel Biosciences is an early-stage startup with proprietary technology to enhance intracellular drug delivery. By combining our endosomal escape platform with small molecule, antisense, protein-based drugs, or complementary delivery technology, we provide our partners with powerful tools for creating next-generation therapeutics.
